Company profile
Actio Biosciences company profile
Actio Biosciences develops genetics‑led therapies for rare and common diseases. The company applies human genetic insights and precision medicine approaches to identify drug targets and advance a pipeline including candidates for Charcot‑Marie‑Tooth disease type 2C (TRPV4 inhibitor ABS‑0871) and KCNT1‑related epilepsy (ABS‑1230). It conducts preclinical and Phase 1 studies to evaluate safety, tolerability, and pharmacokinetics for its lead programs. The company also engages in collaboration, licensing, and clinical trial planning to support development and potential expansion into more common indications.
Business identity
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2021-01-01
Headquarters
- Headquarters
- Wonewoc, Wisconsin, United States
- Postal code
- 92130
- Country code
- US
- Continent
- North America